Form 4: Charles River Laboratories International Executive Reports S
Insider Transaction (Form 4)
Joseph W Laplume, EVP, Corp Strategy & Develop of Charles River Laboratories International, Inc., reported a transaction in 257 shares of common stock on August 10, 2026.
Summary
- Bona fide gift: disposed of 257 Common Stock on August 10, 2026; holds 31,041 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joseph W Laplume — Officer (EVP, Corp Strategy & Develop)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Bona fide gift | Common Stock | 257 | — | — | 31,041 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Bona fide gift (257 shares) |
Keywords
insider transaction, Form 4, CRL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., neutral, Joseph W Laplume
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.